Malcom Bull the IR manager needs to go he puts off his of investors namely Insto with his arrogance.
Cuv is a public company that lacks publicity and why they got rid of reporting quarterly is beyond my imagination when they are growing revenues/profits and cash in bank.
the pipeline looks good and vitiligo is a certainty of gaining fda approval and yes the distribution centres and good to pump out the products
Ann: Syd Capital Markets Briefing Presentation, page-69
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.85 |
Change
-0.350(2.46%) |
Mkt cap ! $695.0M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.00 | $13.78 | $288.4K | 20.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 382 | $13.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.85 | 37 | 3 |
View Market Depth
| Last trade - 11.21am 01/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |